September 16, 2022

Women and Alzheimer’s Disease (Podcast)

An expert reviews risk factors and prevention strategies specific to women


While Alzheimer’s disease may not be the first condition people think of when it comes to women’s health, two out of three individuals diagnosed with the disease are women. In 2020, Cleveland Clinic opened the first Alzheimer’s disease prevention clinic for women in the United States.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“It’s important to know that there is hope when it comes to Alzheimer’s disease,” says Jessica Caldwell, PhD, a neuropsychologist and Director of the Women’s Alzheimer’s Movement Prevention Center at Cleveland Clinic, part of the Lou Ruvo Center for Brain Health in Las Vegas. “There are things that women — and everyone — can do to start reducing risks.”

In the latest episode of Cleveland Clinic’s Neuro Pathways podcast, Dr. Caldwell takes a close look at women and Alzheimer’s disease, covering:

  • Risk factors for men and women, as well as those that affect women specifically
  • Presentation of Alzheimer’s disease in women
  • The role of estrogen and menopause in brain health
  • Prevention strategies related to modifiable risk factors and behavior changes
  • New research in the field on improved hormone replacement therapy and targeted treatment

Click the podcast player above to listen to the 25-minute episode now, or read on for a short edited excerpt. Check out more Neuro Pathways episodes at clevelandclinic.org/neuropodcast or wherever you get your podcasts.

This activity has been approved for AMA PRA Category 1 Credit™. After listening to the podcast, you can claim your credit here.

Advertisement

Excerpt from the podcast

Podcast host Glen Stevens, DO, PhD: What types of prevention strategies are we looking at for women?

Dr. Caldwell: In my clinic, we focus on two categories of behavior change. One involves working directly on what are termed modifiable risk factors for Alzheimer’s disease. This comes from work published in the Lancet over the past five or six years that shows up to 40% of current cases might have been preventable if we had known about changing behavior 20 years ago. Things on that list include medical conditions such as high blood pressure and diabetes. If women come in at risk for those conditions due to family history, we talk about really watching to avoid those things — taking even more care about diet and exercise than they might otherwise do.

The list of modifiable risk factors also includes things like getting enough physical activity. While we work with every woman on physical activity, there are some women who really need to get moving to a higher degree. It also includes things like reducing alcohol intake. There is a particular level of alcohol above which people actually increase their risk for Alzheimer’s disease. If a woman comes in within that range, then we would work together on how to get that reduced.

In addition to those modifiable risks, of which there are 12, we know a lot about different behaviors that support brain health that aren’t on that list. One example that arises often in the clinic is sleep. We know that sleep is important for memory consolidation. During sleep we clear out amyloid from the brain that’s the protein that builds up in Alzheimer’s. And menopause can disrupt sleep, so frequently we work with women in the clinic to change their routines around sleep. Or if a woman has a more chronic sleep problem, we have her work with a therapist to really routinize her sleep and change some of the dysregulations at play.

Advertisement

Another thing that’s not on the modifiable risk factor list that is of course so important for overall health is nutrition. Women may come in with great diets, or they may be eating a lot of processed food, so we’ll work individually with each woman to try to change things in a way that can be sustainable over time.

Related Articles

23-NEU-4313658-CQD-Hero-650×450-1
December 11, 2023
American Psychiatrists Reveal Changing Attitudes About the Therapeutic Use of Classic Hallucinogens

Study shows a growing openness to the clinical potential of psychedelic treatments

23-NEU-4366965-CQD-Hero-650×450-1
November 20, 2023
Experts Stress Importance of Improved Access to Fentanyl Testing

Urine test strips and point-of-care testing may be key to slowing opioid epidemic

23-NEU-4268008-CQD-Hero-650×450-1
November 10, 2023
Researchers Analyze How COVID-19 Affected Z-Drug Prescribing Patterns With and Without Opioids

Study sheds light on how clinicians addressed their patients’ pain and insomnia during the pandemic

23-NUR-3955459-NN-RecoveryInReachProgram-CQD_650x450
November 1, 2023
Pilot Program Helps Akron General Patients Find Sobriety

Recovery's in Reach provides treatment options, peer support to those struggling with alcohol and drug use

23-NEU-4313660-CQD-Hero-650×450-1
October 31, 2023
Researchers Offer New Paradigm for Managing Adult ADHD

Experts recommend task-focused strategy for monitoring treatment

23-NEU-4214118-CQD-Hero-650×450-1
October 27, 2023
75 Years Later: Cleveland Clinic Recalls Researchers’ Pivotal Role in Discovery of Serotonin

Finding changes the treatment landscape of psychiatric illness

Dylan Wint, MD
August 22, 2023
The Difficult, Essential Talk About Dementia

Patients benefit when doctors disclose with care

23-NEU-4048109-virtual-shared-medical-appointment_650x450
August 1, 2023
Hybrid CBT-I Model Expands Access to Behavioral Sleep Care for Patients With Insomnia

Combining group telehealth sessions with one-on-one sessions shortens time to follow-up care

Ad